MedTrace Logo

Mean Platelet Volume and Its Relation to Risk Stratification of Myelodysplastic Syndromes

NCT05204953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2022-01-24

No results posted yet for this study

Summary

The myelodysplastic syndromes (MDS) are a group of myeloid neoplasms characterized by abnormal differentiation and maturation of myeloid cells, reduced bone marrow (BM) function, and a genetic instability with enhanced risk to transform to secondary acute myeloid leukemia, AML

Conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • youssreya A Ahmad, MD · Assiut University

  • Ahmad F Thabet, MD · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-10-31
Completion
2015-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05204953 on ClinicalTrials.gov